The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure
- PMID: 38435143
- PMCID: PMC10907924
- DOI: 10.7759/cureus.53368
The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure
Abstract
Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.
Keywords: immunomodulation; in vitro fertilization; intralipid; intravenous lipid emulsion; recurrent pregnancy loss; uterine natural killer cells.
Copyright © 2024, Anya et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- In memory of Arvid Wretlind 1919 - 2002. Isaksson B, Hambraeus L, Vinnars E, Samuelson G, Larsson J, Asp NG. Food Nutr Res. 191920022002;46:117.
-
- Computerized energy balance and complications in critically ill patients: an observational study. Dvir D, Cohen J, Singer P. Clin Nutr. 2006;25:37–44. - PubMed
-
- Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Anesthesiology. 1998;88:1071–1075. - PubMed
Publication types
LinkOut - more resources
Full Text Sources